Quazomotide

Quazomotide, a class II peptide epitope of WT1 with the sequence RSDELVRHHNMHQRNMTKL, elicits a peptide-specific CD4 (+) response to target WT1 (+) tumor cells. It serves both as an immunological agent for active immunization and as an antineoplastic agent [1] [2].

[C@@H](CC1=CN=CN1)(NC([C@H](CC2=CN=CN2)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCCNC(=N)N)N)=O)CO)=O)CC(O)=O)=O)CCC(O)=O)=O)CC(C)C)=O)[C@H](C)C)=O)CCCNC(=N)N)=O)=O)C(N[C@H](C(N[C@H](C(N[C@@H](CC3=CN=CN3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(O)=O)=O)CCCCN)=O)[C@@H](C)O)=O)CCSC)=O)CC(N)=O)=O)CCCNC(=N)N)=O)CCC(N)=O)=O)=O)CCSC)=O)CC(N)=O)=O